GILD - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan Gilead Sciences Inc

Logo korporat perusahaan Gilead Sciences, Inc. (GILD)

Historical quarterly EPS growth demonstrates profit dynamics as Gilead Sciences, Inc. (GILD) pivots toward CAR-T therapy and oncology, with -19.80 reflecting the most recent metric value. Leadership in virology is sustained by recruiting top scientists and providing high compensation. Business development relies on strategic partnerships with startups and joint clinical trials.

Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan gilead.com (GILD): kanggo periode 04.07.2022 - 18.11.2026

Ringkesan rincian data analitis gilead.com (GILD)

- nilai pasar lan prakiraan target analis:
- statistik kapitalisasi pasar:
Pambiji fundamental:gilead.com - GILD
Barang unggulan Gilead Sciences, Inc.

For Gilead Sciences, Inc. (GILD), profit dynamics determine the effectiveness of the transition from HIV therapy dominance to the oncology segment. This metric is calculated as the percentage change in net earnings per share compared to the same period last year. By analyzing this quarterly earnings per share chart, investors can assess the real speed of capital growth. A positive trend confirms successful portfolio diversification via Trodelvy. The stability of this metric guarantees the sustainability of dividend payments.

Analisis perusahaan pesaing

Cidara Corp (CDTX) - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|Novavax, Inc. - Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan CVAC|Wutah bathi EPS kuartalan valneva.com|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan VIR (Vir Biotechnology)|Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan SIGA Technologies Inc|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Emergent Bio EBS|Wutah bathi EPS kuartalan Atea Pharmaceuticals AVIR|IVVD - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|ENTA (Enanta Pharmaceuticals) - Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan|INO (Inovio) - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|HLVX (HilleVax Inc) - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|KLRS (Kalaris Therapeutics Inc.) - Wutah bathi EPS kuartalan|Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan DYAI (Dyadic International)|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan NNVC (NanoViricides)|TLPH (Talphera, Inc.) - Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Cocrystal Pharma Inc COCP|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan TRAW|Dogwood Therapeutics Inc. - Wutah bathi EPS kuartalan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan Qualigen Corp|ALVR (AlloVir Bio) - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan VBI Vaccines, Inc.|VIRI (virios.com) - Wutah bathi EPS kuartalan|Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan VXRT (Vaxart, Inc.)